SG3 Management’s Globus Medical GMED Stock Holding History

SG3 Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,000	Closed	-$74K	–	565
2022 Q1	$74K	Buy	+1,000	New	+$69.5K	﹤0.01%	850

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SG3 Management's GMED Position: Q2 2022 in Review

SG3 Management sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 1,000 shares — an estimated $74K sold.

SG3 Management first reported a position in GMED in Q1 2022 and held it in 1 quarter. The position peaked at $74K in Q1 2022. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

SG3 Management reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
SG3 Management sold 1,000 Globus Medical shares in Q2 2022, an estimated $74K.
SG3 Management first reported a position in Globus Medical in Q1 2022 and held it in 1 quarter.
SG3 Management's Globus Medical position peaked at $74K in Q1 2022.
364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.